A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up

Figure 3

Comparisons of CGMS glucose parameters: (a) 24h-MBG, (b) 24h-SDBG, (c) 24h-SDBG, (d) 24h-MAGE, and (e) 24h-MAGE at baseline and after treatment in the dulaglutide and glimepiride groups.

(a)

(b)

(c)

(d)

(e)